ONESOURCE SPECIALTY PHARMA
Back to Balance Sheet
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹135 Cr | ₹155 Cr | - | - | - |
What is the latest Deferred Tax Assets / Liabilities ratio of ONESOURCE SPECIALTY PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹135 Cr |
| Mar2025 | ₹155 Cr |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
How is Deferred Tax Assets / Liabilities of ONESOURCE SPECIALTY PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹135 Cr | -13.12 | |
| Mar2025 | ₹155 Cr | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | - | |
Compare Deferred Tax Assets / Liabilities of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹18,165.0 Cr | -0.6% | 18.7% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -0.6% |
18.7% |
-8.7% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses